» Articles » PMID: 10974445

Comparison of Treatment Plans Involving Intensity-modulated Radiotherapy for Nasopharyngeal Carcinoma

Overview
Specialties Oncology
Radiology
Date 2000 Sep 7
PMID 10974445
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare intensity-modulated radiotherapy (IMRT) treatment plans with conventional treatment plans for a case of locally advanced nasopharyngeal carcinoma.

Methods And Materials: The study case was planned using two types of IMRT techniques, as well as a three-dimensional conformal radiotherapy technique (3D-CRT), and a traditional treatment method using bilateral opposing fields. These four plans were compared with respect to dose conformality, dose-volume histogram (DVH), dose to the sensitive normal tissue structures, and ease of treatment delivery.

Results: The planned dose distributions were more conformal to the tumor target volume in the IMRT plans than those in the conventional plans. With similar dose coverage of the clinical target volume (CTV), defined as delivery of minimum of 60 Gy to >/= 95% of CTV, the IMRT plans achieved better sensitive normal tissue structure sparing, while concomitantly delivering a minimum dose of 68 Gy to >/= 95% of the gross tumor volume (GTV) at a higher dose per fraction.

Conclusions: Compared to conventional techniques, IMRT techniques provide improved tumor target coverage with significantly better sparing of sensitive normal tissue structures in the treatment of locally advanced nasopharyngeal carcinoma. With improvement of the delivery efficiency, IMRT should provide the optimal treatment for all nasopharyngeal carcinoma. Further studies are needed to establish the true clinical advantage of this new modality.

Citing Articles

Case Reports: A role of postoperative radiation therapy in completely resected early stage intrathyroid thymic carcinoma: a case report and literature review of the diagnosis and treatment.

Cui A, Du Y, Hou C, Zhang L, Sun L, He H Front Oncol. 2023; 13:1234961.

PMID: 37849817 PMC: 10577444. DOI: 10.3389/fonc.2023.1234961.


The 100 most cited papers in nasopharyngeal carcinoma between 2000 and 2019: a bibliometric study.

Xing C, Lin M, Luo W, Chen L, Wu S, Cai Y Transl Cancer Res. 2023; 12(4):848-858.

PMID: 37180645 PMC: 10174760. DOI: 10.21037/tcr-22-2621.


A Prospective Cohort Study Analyzing Radiation-Induced Xerostomia and Quality of Life of Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy and 3D Conformal Radiotherapy Techniques at a Tertiary Cancer Center in Eastern India.

Sahoo Sr B, Padhi S, Patra A, Mahapatra B, Mishra T, Mishra S Cureus. 2023; 15(3):e36442.

PMID: 37090370 PMC: 10115659. DOI: 10.7759/cureus.36442.


Concurrent chemoradiotherapy versus radiotherapy alone for stage II nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Xue Y, Li G, Xie T, Xu H, Xu T, Li Z Eur Arch Otorhinolaryngol. 2023; 280(7):3097-3106.

PMID: 37079074 DOI: 10.1007/s00405-023-07943-9.


Multimodal Data Integration to Predict Severe Acute Oral Mucositis of Nasopharyngeal Carcinoma Patients Following Radiation Therapy.

Dong Y, Zhang J, Lam S, Zhang X, Liu A, Teng X Cancers (Basel). 2023; 15(7).

PMID: 37046693 PMC: 10093711. DOI: 10.3390/cancers15072032.